Paul Schimmel, Director at aTYR PHARMA INC (LIFE), bought 25,000 shares at $2.28 ($57K) on 2016-12-21, disclosed to the SEC on 2016-12-22.
Open-market purchase of $57k LIFE by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.27 | 15,000 | $34K | 59.9% |
| 2 | $2.28 | 10,000 | $23K | 40.1% |
| Total | $2.27 avg | 25,000 | $57K | 100% |
| Filing → |
| ATYR | BUY | 2024-07-24 | $256K | — | Filing → |
| LIFE | BUY | 2023-05-11 | $450K | — | Filing → |
| LIFE | BUY | 2021-09-22 | $2.0M | — | Filing → |